Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 2/20 | 0.39 |
| ▸ | P2RX7 | Q99572 | 6/20 | 0.38 |
| ▸ | TP53 | P04637 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11294182 | 0.99 | ALDH1A1 (0.45) | ALDH1A1TSHRHTTMAPK1SMN1; SMN2 | |
| SCHEMBL11293575 | 0.85 | ALDH1A1 (0.46) | ALDH1A1TSHRSMN1; SMN2THRBP2RX7 | |
| SCHEMBL3051654 | 0.84 | P2RX7 (0.50) | THRBP2RX7TP53MAPTLMNA | |
| Hydrochloric Acid SCHEMBL11299080 | 0.84 | ALDH1A1 (0.45) | ALDH1A1TSHRSMN1; SMN2THRBP2RX7 | |
| SCHEMBL3051670 | 0.81 | P2RX7 (0.48) | ALDH1A1HTTSMN1; SMN2THRBP2RX7 | |
| SCHEMBL22660960 | 0.78 | ALDH1A1 (0.45) | ALDH1A1TSHRHTTMAPK1SMN1; SMN2 | |
| SCHEMBL3047241 | 0.78 | SLC6A2 (0.55) | ALDH1A1SMN1; SMN2P2RX7 | |
| SCHEMBL28210928 | 0.77 | ALDH1A1 (0.45) | ALDH1A1TSHRHTTMAPK1SMN1; SMN2 | |
| SCHEMBL3040850 | 0.72 | DPP4 (0.46) | P2RX7LMNA | |
| SCHEMBL3260671 | 0.72 | LMNA (0.44) | ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0043141-A1 | Pharmaceutical compositions having antiviral activity for topical administration and the use of 1-(substituted phenyl)-5-(4-morpholinyl)-1-penten-3-one compounds for the preparation of pharmaceutical compositions having an antiviral effect | MERRELL DOW PHARMACEUTICALS INC. (US) | 1982-01-06 | — | — | EP | disclosed |